Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.25.1 (
proteasome
)
28,817
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Cadmium is a substantial industrial and environmental pollutant which seriously impairs erythropoiesis. Cd has been demonstrated to aggravate anemia by suppressing erythropoietin gene expression in anemic patients. As hypoxic induction of erythropoietin mRNA depends on a transcription factor, hypoxia-inducible factor 1 (HIF-1), we hypothesized that Cd suppresses the hypoxic activation of HIF-1. In hypoxic Hep3B cells, all mRNAs of various genes, which are known to be upregulated by HIF-1 activation under hypoxia, were suppressed by Cd in a dose-dependent manner. Cd inhibited the hypoxia-induced activity of luciferase in 293 cells which was transfected with a reporter plasmid carrying a hypoxia response element. By electrophoretic mobility gel shift assay, Cd inhibited the DNA-binding activity of HIF-1 in hypoxic Hep3B cells. Cd reduced the amount of HIF-1alpha protein in hypoxia, whereas it didn't affect
HIF-1 alpha
mRNA levels. Moreover, Cd inhibited HIF-1alpha accumulation induced by cobalt and desferrioxamine. Antioxidants and a proteasome inhibitor prevented the HIF-1alpha degradation caused by Cd. The possibility that oxidative stress mediates this action of Cd was examined. Cd didn't affect protein oxidation and reduced glutathione levels in hypoxic cells. These results indicate that Cd triggers a redox/
proteasome
-dependent degradation of HIF-1alpha protein, reducing HIF-1 activity and in turn suppressing the hypoxic induction of hypoxia-inducible genes.
...
PMID:Cadmium blocks hypoxia-inducible factor (HIF)-1-mediated response to hypoxia by stimulating the proteasome-dependent degradation of HIF-1alpha. 1086 24
In normoxic cells the hypoxia-inducible factor-1 alpha (
HIF-1 alpha
) is rapidly degraded by the ubiquitin-
proteasome
pathway, and activation of
HIF-1 alpha
to a functional form requires protein stabilization. Here we show that the product of the von Hippel-Lindau (VHL) tumor suppressor gene mediated ubiquitylation and proteasomal degradation of
HIF-1 alpha
under normoxic conditions via interaction with the core of the oxygen-dependent degradation domain of
HIF-1 alpha
. The region of VHL mediating interaction with
HIF-1 alpha
overlapped with a putative macromolecular binding site observed within the crystal structure of VHL. This motif of VHL also represents a mutational hotspot in tumors, and one of these mutations impaired interaction with
HIF-1 alpha
and subsequent degradation. Interestingly, the VHL binding site within
HIF-1 alpha
overlapped with one of the minimal transactivation domains. Protection of
HIF-1 alpha
against degradation by VHL was a multistep mechanism, including hypoxia-induced nuclear translocation of
HIF-1 alpha
and an intranuclear hypoxia-dependent signal. VHL was not released from
HIF-1 alpha
during this process. Finally, stabilization of
HIF-1 alpha
protein levels per se did not totally bypass the need of the hypoxic signal for generating the transactivation response.
...
PMID:Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein. 1094 13
Adaptation to hypoxia is a topic of considerable clinical relevance, as it influences the pathophysiology of anaemia, polycythaemia, tissue ischaemia and cancer. A growing number of physiologically relevant genes are regulated in response to changes in intracellular oxygen tension. These include genes encoding erythropoietin, vascular endothelial growth factor and tyrosine hydroxylase. Studies on the regulation of the erythropoietin gene have provided insights into the common mechanism of oxygen sensing and signal transduction, leading to activation of the hypoxia-inducible transcription factor 1 (HIF-1). Activation of HIF-1 by hypoxia depends on rescue of its alpha-subunit from oxygen-dependent degradation in the
proteasome
, allowing it to form a heterodimer with HIF-1 beta. This then translocates to the nucleus. There, HIF-1 assembles with a highly conserved orphan nuclear receptor, HNF-4, and a critical transcriptional adaptor, p300. This complex binds to a 3' enhancer on the erythropoietin gene, enabling transcription of erythropoietin. HIF-1 also activates other genes, the cis-acting elements of which contain cognate hypoxia response elements. There is growing evidence that the oxygen sensor is a flavohaem protein and that the signal transduction pathway involves changes in the level of intracellular reactive oxygen intermediates. We have recently cloned a novel fusion protein called cytochrome b5/b5 reductase, which is a cyanide-insensitive NADPH oxidase and, therefore, a candidate to be the oxygen sensor. This flavohaem protein is widely expressed in cell lines and tissues, with localization in the perinuclear space. In the presence of oxygen and iron, it may induce oxidative modifications that target
HIF-1 alpha
for ubiquitination and degradation.
...
PMID:Detecting and responding to hypoxia. 1181 5
HIF-1 alpha
is a normally labile proangiogenic transcription factor that is stabilized and activated in hypoxia. Although the von Hippel Lindau (VHL) gene product, the ubiquitin ligase responsible for regulating
HIF-1 alpha
protein levels, efficiently targets
HIF-1 alpha
for rapid
proteasome
-dependent degradation under normoxia,
HIF-1 alpha
is resistant to the destabilizing effects of VHL under hypoxia.
HIF-1 alpha
also associates with the molecular chaperone Hsp90. To examine the role of Hsp90 in
HIF-1 alpha
function, we used renal carcinoma cell (RCC) lines that lack functional VHL and express stable
HIF-1 alpha
protein under normoxia. Geldanamycin (GA), an Hsp90 antagonist, promoted efficient ubiquitination and
proteasome
-mediated degradation of
HIF-1 alpha
in RCC in both normoxia and hypoxia. Furthermore,
HIF-1 alpha
point mutations that block VHL association did not protect
HIF-1 alpha
from GA-induced destabilization. Hsp90 antagonists also inhibited
HIF-1 alpha
transcriptional activity and dramatically reduced both hypoxia-induced accumulation of VEGF mRNA and hypoxia-dependent angiogenic activity. These findings demonstrate that disruption of Hsp90 function 1) promotes
HIF-1 alpha
degradation via a novel, oxygen-independent E3 ubiquitin ligase and 2) diminishes
HIF-1 alpha
transcriptional activity. Existence of an Hsp90-dependent pathway for elimination of
HIF-1 alpha
predicts that Hsp90 antagonists may be hypoxic cell sensitizers and possess antiangiogenic activity in vivo, thus extending the utility of these drugs as therapeutic anticancer agents.
...
PMID:Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1 alpha-degradative pathway. 1205 35
Hypoxia-inducible factor 1 (HIF-1) is the major transcription factor activated during hypoxia. It is composed of
HIF-1 alpha
and HIF-1 beta subunits. While HIF-1 beta is constitutively expressed,
HIF-1 alpha
is targeted to
proteasome
degradation under normoxic conditions. Under hypoxia,
HIF-1 alpha
is stabilized and heterodimerizes with HIF-1 beta. Iron chelators have also been reported to stabilize
HIF-1 alpha
protein and activate HIF-1. In this study, we investigated the effects of dibenzoylmethane (DBM), a natural dietary compound and an iron chelator, on HIF-1 pathway. We found that DBM increases
HIF-1 alpha
protein levels in a dose- and time-dependent manner. This induction was accompanied with activation of HIF-1, measured by reporter gene assay and increased production of its downstream target, the vascular endothelial growth factor. Mechanistically,
HIF-1 alpha
was stabilized by DBM at a step prior to ubiquitination. The effect of DBM on HIF-1 and its low toxicity profile might be therapeutically beneficial in ischemic diseases.
...
PMID:Dibenzoylmethane, a natural dietary compound, induces HIF-1 alpha and increases expression of VEGF. 1264 99
Three HIF-alpha prolyl-4-hydroxylases (PHDs) (named PHD1, PHD2, and PHD3) effect the
proteasome
-mediated degradation of HIF by catalyzing the hydroxylation of key proline residues in the
HIF-1 alpha
subunit under normoxic conditions. When oxygen tension is reduced, PHD-mediated hydroxylation cannot occur,
HIF-1 alpha
accumulates in the nucleus, resulting in HIF-mediated gene transcription. In the present study, the expression and regulation of PHD mRNA and HIF protein expression was examined in human tissues and primary cells of cardiovascular origin. Treatment of human cardiac myocytes, smooth muscle cells, and endothelial cells with hypoxia or CoCl(2), a hypoxia mimic, resulted in a significant time-dependent increase in PHD3, but not PHD1 or PHD2, mRNA levels, which correlated with an increase in
HIF-1 alpha
protein expression. Overexpression studies revealed that PHD3 levels influence
HIF-1 alpha
stability in both normoxic and hypoxic conditions, suggesting that PHD3 may participate in a feedback loop controlling HIF activity.
...
PMID:Differential regulation of HIF-1 alpha prolyl-4-hydroxylase genes by hypoxia in human cardiovascular cells. 1267 May 3
Tumors utilize hyperactivation of the phosphatidylinositol 3-kinase (PI3K)/AKT signaling pathway to cope with deleterious environmental conditions. Activation of the PI3K/AKT pathway has been shown to increase protein expression of the alpha subunit of the hypoxia-inducible factor (HIF) 1, a key regulator of oxygen homeostasis. Elevated levels of
HIF-1 alpha
induce expression of genes with critical roles in angiogenesis, erythropoiesis, and glucose metabolism, processes that are essential for tumor expansion. Here we examine the involvement of FOXO4 (also known as AFX), a member of the forkhead transcription factor superfamily that is negatively regulated by the PI3K/AKT pathway, in the regulation of
HIF-1 alpha
protein expression. Nuclear expression of FOXO4 results in the suppression of various responses to hypoxia, including decreased vascular endothelial growth factor, glucose transporter 1, and erythropoietin expression. Interestingly, FOXO4 down-regulates the
HIF-1 alpha
protein levels, consistent with the lack of hypoxia responsiveness. Previous results have revealed a role for prolyl hydroxylation and resultant von Hippel-Lindau protein (pVHL) interactions in the ubiquitin-
proteasome
-mediated degradation of
HIF-1 alpha
. However, neither inhibition of prolyl hydroxylases nor mutation of
HIF-1 alpha
-hydroxylated prolines involved with pVHL-mediated binding inhibits the observed FOXO4-mediated down-regulation of
HIF-1 alpha
. These results suggest a novel alternate mechanism for hypoxic regulation that is dependent upon the level of activation of FOXO4-mediated transcription.
...
PMID:The forkhead transcription factor FOXO4 induces the down-regulation of hypoxia-inducible factor 1 alpha by a von Hippel-Lindau protein-independent mechanism. 1276 Dec 17
Geldanamycin (GA) binds to heat shock protein 90 (Hsp90) and interferes with its function which is to protect various cellular proteins involved in signaling, growth control, and survival from ubiquitination and subsequent degradation by the
proteasome
. Recently, we demonstrated that GA inhibited migration of glioma cells in vitro associated with downregulation of hypoxia-inducible factor (
HIF-1 alpha
) and phosphorylation of focal adhesion kinase (FAK) (Zagzag et al., 2003, J Cell Physiol 196:394-402). Here, we have investigated the mechanisms through which GA treatment of the T98G glioma cell line induces apoptosis. We found that GA treatment induced cell death in a caspase-dependent manner through activation of caspase-3 and PARP cleavage together with release of cytochrome c and apoptosis inducing factor (AIF) from the mitochondria. Use of synchronized T98G cells showed that GA treatment of glioma cells during S-phase enhanced cytotoxicity followed by M-phase arrest, resulting in mitotic catastrophe. In addition, apoptosis was associated with the downregulation of the survival protein, phosphorylated Akt (pAkt), an important signaling protein in the PI3K pathway, that is overexpressed in many cancers including gliomas. Given that many glioma tumors show deregulation of the PI3K signaling pathway, either through loss of the tumor suppressor protein PTEN or overexpression of the growth factor EGFR, the ability to identify different subsets of patients using simple immunohistochemistry for the presence of absence of pAkt could enable selection of the appropriate kinase inhibitor, such as GA, for drug therapy. Based on our data presented here, GA or its analogs may have potential in the treatment of glioma.
...
PMID:Geldanamycin induces mitotic catastrophe and subsequent apoptosis in human glioma cells. 1538 45
The hypoxia-inducible factor-1 alpha (
HIF-1 alpha
) is a transcription factor that mediates adaptive cellular responses to decreased oxygen availability (hypoxia). At normoxia,
HIF-1 alpha
is targeted by the von Hippel-Lindau tumor suppressor protein (pVHL) for degradation by the ubiquitin-
proteasome
pathway. In the present study we have observed distinct cell-type-specific differences in the ability of various tested pVHL-interacting subfragments to stabilize
HIF-1 alpha
and unmask its function at normoxia. These properties correlated with differences in subcellular compartmentalization and degradation of
HIF-1 alpha
. We observed that the absence or presence of nuclear localization or export signals differently affected the ability of a minimal
HIF-1 alpha
peptide spanning residues 559 to 573 of mouse
HIF-1 alpha
to stabilize endogenous HIFalpha and induce HIF-driven reporter gene activity in two different cell types (primary mouse endothelial and HepG2 hepatoma cells). Degradation of
HIF-1 alpha
occurred mainly in the cytoplasm of HepG2 cells, whereas it occurs with equal efficiency in nuclear and cytoplasmic compartments of primary endothelial cells. Consistent with these observations, green fluorescent protein-
HIF-1 alpha
is differently distributed during hypoxia and reoxygenation in hepatoma and endothelial cells. Consequently, we propose that differential compartmentalization of degradation of
HIF-1 alpha
and the subcellular distribution of
HIF-1 alpha
may account for cell-type-specific differences in stabilizing
HIF-1 alpha
protein levels under hypoxic conditions.
...
PMID:Cell-type-specific regulation of degradation of hypoxia-inducible factor 1 alpha: role of subcellular compartmentalization. 1673 27
The ubiquitin-
proteasome
pathway (UPP) is involved in regulation of multiple cellular processes.
Hypoxia-inducible factor 1 alpha
(
HIF-1 alpha
) is a prototypic target of the UPP and, as such, is stabilized under conditions of proteasomal inhibition. Using carbonic anhydrase IX (CAIX) and vascular endothelial growth factor (VEGF) expression as paradigmatic markers of HIF-1 activity, we found that proteasomal inhibitors (PI) abrogated hypoxia-induced CAIX expression in all cell lines tested and VEGF expression in two out of three. Mapping of the inhibitory effect identified the C-terminal activation domain (CAD) of
HIF-1 alpha
as the primary target of PI. PI specifically inhibited the
HIF-1 alpha
CAD despite activating the
HIF-1 alpha
coactivator p300 and another p300 cysteine/histidine-rich domain 1-dependent transcription factor, STAT-2. Coimmunoprecipitation and glutathione S-transferase pull downs indicated that PI does not disrupt interactions between
HIF-1 alpha
and p300. Mutational analysis failed to confirm involvement of sites of known or putative posttranslational modifications in regulation of
HIF-1 alpha
CAD function by PI. Our data provide evidence for the counterintuitive hypothesis that inhibition of HIF-1 function could be responsible for at least some of the antitumor effects of proteasomal inhibition. Further studies of the mechanism of the PI-induced attenuation of HIF-1alpha will provide important, potentially novel insight into regulation of HIF-1 activity and possibly identify new targets for HIF-directed therapy.
...
PMID:Proteasomal inhibition attenuates transcriptional activity of hypoxia-inducible factor 1 (HIF-1) via specific effect on the HIF-1alpha C-terminal activation domain. 1684 40
1
2
Next >>